A3CL77 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibcwm7pwjwo2vypijwi6albayidg5pakd2f77epu55v6xbxvuxunm/metadata.json
IPFS of structure file: 
bafybeifdio2o43zopgxcg7opafpqdku27sdonb7ljsa6sgp2ygvq4ipabq/AF-A3CL77-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xf18fe12B070cdC0C52a8561c9578bA09cAa78F5F
First NFT owner address (bech32): 
genesis17x87z2c8pnwqc54g2cwf2796p8920r6levwpgv
Current NFT ID #166930 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166930
Accession (UniProt):
A3CL77
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
STREPTOCOCCUS SANGUINIS (STRAIN SK36)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A3CL77 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A3CL77|HEM1_STRSV Glutamyl-tRNA reductase OS=Streptococcus sanguinis (strain SK36) OX=388919 GN=hemA PE=3 SV=1 MHLLYVGLTHRETPLTILEKAHFSDQEGLKALKLLKREKSILENIILSTCNRTELYLVVDQLHTGRYYSKHFLADWFQIPVKELEEYLVFREGDEALRHLLRVSIGLESKIVGESQVLGQLKQAFLTAQDAGTTGIVLNQAFKQALTFAKRMHDTYRINDRPISIGLTAIQELDRMGLDYSTKKIAVIGLGEIGQLVTKYALQRPFESVMLLNRTVSKAQAFLTEDRVSAHGWDELEEVLADADVVFSAVKTEEYIIFPSMLKEGAIVFDLCLPRSCHPSSSLKLYNIENLTNQLEQYKAERQEIAGRIALEIDEELVKFADWRQQLGIIPLIQEIRDKALEAQASAMESLNRKIPDLTEREQKQISKHMKSIINQVLKEPILQLKELSVGEHSDYDIALIAKIFGLHRERGKDEGH